| Market Cap (cr): | ₹2,650 Cr | Book Value: | ₹56.7 |
|---|---|---|---|
| Lot Size: | 100 shares | 52 Week High: | ₹275 |
| 52 Week Low: | ₹70 | EPS: | 4.39 |
| Demat Account: | Required | PB: | 4.7 |
| Face Value: | ₹10 | Debt To Equity: | 0.00 |
| No Of Shares: | 10 crore | Url: | http://www.vpslakeshorehospital.com/ |
Overview :
.Company Overview
Lakeshore Hospital & Research Centre Limited (“VPS Lakeshore”), based in Kochi, Kerala, is one of South India’s most advanced multi-specialty tertiary care hospitals. Known for its best-in-class transplant programs, comprehensive clinical departments, and a culture of clinical and operational excellence, Lakeshore continues to achieve strong financial stability, growth in patient revenue, and reputation for quality. The hospital’s strengths include advanced facilities, a large team of specialized doctors, and ongoing investment in technology and clinical talent.
Board of Directors
| Name | Designation |
|---|---|
| Dr. Vayalil Parambath Shamsheer | Chairman & MD |
| Mr. P. M. Sebastian | Vice Chairman |
| Mr. S. K. Abdulla | Managing Director |
| Mr. K. N. Prabhakaran Nair | Director |
| Dr. K. V. Johny | Director |
| Mr. P. D. Mathew | Director |
| Mr. A. Janardhana Pai | Independent Non-Executive Director |
| Mr. M. M. Mathai | Director |
| Mr. Job Varghese | Director |
| Dr. K. Chithrathara | Woman Director |
| Mr. V. Venugopal | Independent Director |
| Mr. Hari Mohan | Director |
| Mr. Reuben Joseph | Independent Non-Executive Director |
| Mr. Gireesh Kumar E | CFO |
| Mr. R. Muraleedharan | Company Secretary |
Company Incorporation Details
| Attribute | Details |
|---|---|
| Company Name | Lakeshore Hospital & Research Centre Limited |
| CIN | U85110KL1996PLC010260 |
| Incorporation Date | March 16, 1996 |
| Registered Office | No XVI/612, Maradu, Nettoor P.O, Kochi, Kerala – 682040 |
| info@lakeshorehospital.com | |
| Phone | +91 484 2701032 |
| Face Value | ₹10 |
| ISIN | Available on confirmation for demat deal |
| Lot Size | 100 shares |
| Demat Account | Mandatory |
| Website | www.vpslakeshorehospital.com |
Shareholding Pattern (FY2024–25)
| Category | % Holding |
|---|---|
| Promoters/Directors/Families | 77.78 |
| Public & Other Investors | 22.21 |
Major shareholders include Dr. Shamsheer Vayalil Parambath (42.62%) and Mr. Yusuff Ali M. A. (18.80%).
Sector
- Industry: Healthcare Services
- Segment: Hospital, Diagnostics, Critical Care, Transplant
Why Choose Arms Securities?
Experience expert support, transparent price discovery, and regulatory safety in every Lakeshore Hospital & Research Centre Limited unlisted share deal—trust Arms Securities for your investments.
Balance Sheet of Lakeshore Hospital Unlisted Shares
in ₹ Cr.
| category | FY25 | FY24 | FY23 | FY22 |
|---|---|---|---|---|
| Equity | 422.28 | 400.30 | 373.52 | 331.28 |
| Liabilities | 111.02 | 107.42 | 126.72 | 132.71 |
| Total Equity and Liabilities | 533.30 | 507.72 | 500.24 | 463.99 |
| Net Fixed Assets | 346.23 | 350.74 | 332.31 | 345.84 |
| Capital Work-in-progress | 4.66 | 1.89 | 5.67 | 0.15 |
| Other Non current Assets | 21.26 | 31.47 | 19.41 | 27.53 |
| Current Assets | 161.15 | 123.62 | 142.85 | 90.45 |
| Total Assets | 533.30 | 507.72 | 500.24 | 463.97 |
Profit and Loss of Lakeshore Hospital Unlisted Shares
in ₹ Cr.
| category | FY25 | FY24 | FY23 | FY22 |
|---|---|---|---|---|
| Net Revenue | 407.52 | 396.22 | 419.04 | 358.47 |
| Total Operating Cost | 336.67 | 323.25 | 317.23 | 276.80 |
| Operating Profit (EBITDA) | 70.85 | 72.97 | 101.81 | 81.67 |
| Other Income | 8.23 | 6.67 | 5.42 | 3.18 |
| Depreciation and Amortization Expense | 26.05 | 23.70 | 22.69 | 21.46 |
| Profit Before Interest and Taxes | 53.03 | 55.94 | 84.54 | 63.39 |
| Finance Costs | 0.33 | 0.93 | 2.11 | 2.57 |
| Profit Before Tax and Exceptional Items Before Tax | 52.70 | 55.01 | 82.43 | 60.82 |
| Profit Before Tax | 52.70 | 55.01 | 82.43 | 60.82 |
| Income Tax | 13.62 | 11.13 | 24.90 | 17.90 |
| Profit for the Period from Continuing Operations | 39.08 | 43.89 | 57.53 | 42.92 |
| Profit for the Period | 39.08 | 43.89 | 57.53 | 42.92 |
Net Sales (in cr.)
Total Income (in cr.)
Operating Profit (in cr.)
Net Profit (in cr.)
Shareholder Funds (in cr.)
Total Assets (in cr.)
Frequently Ask Question
Have Your Any Question?
Open a demat account, share KYC, and trade securely via Arms Securities.
Use a Delivery Instruction Slip (DIS) for demat-to-demat transfer; Arms Securities facilitates fully compliant settlement.
No lock-in for regular OTC trades; check for pre-IPO/ESOP restrictions.
Only via regulated, SEBI-compliant brokers like Arms Securities.
A DIS enables off-market transfer of shares from seller to buyer’s demat account.
Yes, if executed through SEBI-registered brokers and settled in demat mode.
Short-term (<24 months): slab rate; long-term (≥24 months): 20% with indexation.
Yes, SEBI prescribes broker, KYC, and transfer process for investor safety.
Through verified promoters, early investors, and eligible demat holders.
Subscribe for Arms Securities alerts or visit vpslakeshorehospital.com.